Z
Zhejiang Yichenkang Biotechnology
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| CJC-1295 | B | 5 | 7.0 | 5.3 | 7.9 | 10 Jun 2025 |
| GHK-Cu | C | 4 | 5.5 | 4.8 | 6.8 | 10 Jul 2025 |
| Semaglutide | C | 6 | 6.2 | 4.5 | 8.0 | 14 Jun 2025 |
| Ipamorelin | C | 6 | 5.9 | 4.1 | 8.0 | 10 Jun 2025 |
| Tirzepatide | C | 8 | 6.4 | 4.4 | 7.7 | 11 Jun 2025 |
| Retatrutide | D | 11 | 7.1 | 3.3 | 10.0 | 11 Jun 2025 |
| BPC-157 | E | 6 | 4.8 | 1.8 | 6.8 | 10 Jun 2025 |
| Melanotan II | E | 4 | 5.3 | 1.7 | 8.0 | 10 Jun 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | B | 2 | 7.2 | 5.8 | 8.6 | 17 May 2026 |
| AA Water | B | 5 | 6.0 | 3.6 | 7.7 | 19 Jan 2026 |
| Adipotide | B | 2 | 6.8 | 6.1 | 7.4 | 26 Jan 2026 |
| AICAR | B | 5 | 6.5 | 4.7 | 9.4 | 17 May 2026 |
| Boldenone Cypionate | B | 5 | 4.5 | 0.8 | 6.8 | 24 May 2026 |
| BPC-157 Arg Oral | X | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 |
| Cartalax | B | 2 | 6.3 | 6.1 | 6.6 | 24 May 2026 |
| Cerebrolysin | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | B | 2 | 6.9 | 6.7 | 7.1 | 21 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | B | 3 | 5.9 | 5.1 | 7.0 | 21 May 2026 |
| Dapoxetine | X | 1 | 7.4 | 7.4 | 7.4 | 13 Feb 2025 |
| DHB (1-Test Cyp) | B | 2 | 5.3 | 4.0 | 6.6 | 19 Jan 2026 |
| EPO | B | 4 | 5.2 | 3.3 | 7.3 | 17 May 2026 |
| Estradiol Cypionate | B | 5 | 5.4 | 2.9 | 8.1 | 21 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | B | 3 | 4.6 | 4.4 | 4.9 | 20 May 2026 |
| Letrozole | B | 3 | 5.8 | 4.1 | 6.8 | 20 May 2026 |
| Lipo-C FAT BLASTER | B | 4 | 6.6 | 5.5 | 8.2 | 21 May 2026 |
| Liraglutide | X | 1 | 7.8 | 7.8 | 7.8 | 2 Jul 2025 |
| Methylene Blue | B | 5 | 5.7 | 3.5 | 8.0 | 21 May 2026 |
| MK-677 (Ibutamoren) | B | 2 | 8.2 | 7.6 | 8.8 | 21 May 2026 |
| MOTS-C | B | 4 | 6.6 | 4.8 | 9.5 | 20 May 2026 |
| MT-1 | B | 2 | 7.0 | 5.5 | 8.6 | 26 Jan 2026 |
| NAD+ Injectable | B | 4 | 6.4 | 4.6 | 8.2 | 17 May 2026 |
| Nandrolone Decanoate (Deca) Raw | B | 4 | 6.3 | 5.3 | 7.0 | 23 May 2026 |
| Pancragen | B | 2 | 5.3 | 3.4 | 7.2 | 24 May 2026 |
| PTD-DBM | B | 2 | 6.8 | 6.7 | 6.9 | 24 May 2026 |
| Selank | B | 3 | 7.5 | 5.1 | 8.9 | 21 May 2026 |
| Semax | B | 2 | 5.7 | 5.6 | 5.8 | 17 May 2026 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | B | 3 | 6.0 | 5.5 | 6.5 | 21 May 2026 |
| SS-31 (Elamipretide) Raw | B | 4 | 6.8 | 4.7 | 10.0 | 24 May 2026 |
| Super Shred | X | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 |
| Superdrol Oil | B | 3 | 6.2 | 4.4 | 7.7 | 19 Jan 2026 |
| Sustanon 400 | B | 4 | 6.4 | 4.6 | 7.8 | 24 May 2026 |
| Test Base (No Ester) | B | 2 | 4.5 | 3.7 | 5.3 | 23 May 2026 |
| Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | B | 4 | 6.0 | 4.6 | 7.3 | 24 May 2026 |
| Turinabol | B | 5 | 5.9 | 5.2 | 6.6 | 17 May 2026 |
| Vilon | B | 3 | 6.6 | 6.0 | 7.6 | 24 May 2026 |
| Winstrol (Stanozolol) | B | 2 | 6.6 | 6.0 | 7.2 | 26 Jan 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Methylene Blue | 7.0 | 10mg | 11.9mg | +18.9% | 96.71% | Lab B |
| 25 May 2026 | Methylene Blue | 6.2 | 50mg | 54.5mg | +9.1% | 99.21% | Lab E |
| 25 May 2026 | NAD+ Injectable | 7.3 | 100mg/ml | 110.4mg/ml | +10.4% | 99.39% | Lab A |
| 25 May 2026 | Sustanon 400 | 6.5 | 100mg/ml | 118.5mg/ml | +18.5% | 98.57% | Lab C |
| 25 May 2026 | Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | 4.4 | 250mg/ml | 298.8mg/ml | +19.5% | 97.42% | Lab E |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.3 | 20mg | 24.7mg | +23.7% | 96.69% | Lab E |
| 24 May 2026 | Boldenone Cypionate | 5.3 | 200mg/ml | 249.5mg/ml | +24.7% | 95.30% | Lab D |
| 24 May 2026 | Lipo-C FAT BLASTER | 5.9 | 300mg/ml | 280.5mg/ml | -6.5% | 98.23% | Lab F |
| 24 May 2026 | Selank | 7.8 | 20mg | 24.1mg | +20.5% | 98.74% | Lab A |
| 24 May 2026 | Super Shred | 7.5 | 300mg/ml | 274.5mg/ml | -8.5% | 99.48% | Lab B |
| 24 May 2026 | Sustanon 400 | 6.8 | 300mg/ml | 282.1mg/ml | -6.0% | 98.48% | Lab E |
| 24 May 2026 | Sustanon 400 | 7.9 | 200mg/ml | 249.7mg/ml | +24.8% | 97.34% | Lab A |
| 24 May 2026 | EPO | 4.5 | 50mg | 45.8mg | -8.4% | 95.52% | Lab D |
| 24 May 2026 | AICAR | 5.2 | 2mg | 2.4mg | +21.3% | 97.71% | Lab A |
| 24 May 2026 | Boldenone Cypionate | 4.0 | 250mg/ml | 221.9mg/ml | -11.2% | 95.66% | Lab D |
| 24 May 2026 | EPO | 5.0 | 2mg | 2.5mg | +24.6% | 96.70% | Lab B |
| 24 May 2026 | Letrozole | 4.4 | 25mg | 24.0mg | -3.8% | 98.19% | Lab F |
| 24 May 2026 | PTD-DBM | 7.6 | 15mg | 15.5mg | +3.3% | 99.88% | Lab B |
| 24 May 2026 | PTD-DBM | 7.7 | 10mg | 10.0mg | -0.3% | 95.99% | Lab B |
| 24 May 2026 | SS-31 (Elamipretide) Raw | 8.0 | 500g | 473.3g | -5.3% | 95.32% | Lab A |
| 24 May 2026 | DHB (1-Test Cyp) | 5.9 | 200mg/ml | 184.6mg/ml | -7.7% | 96.24% | Lab C |
| 23 May 2026 | AA Water | 7.4 | 30mg | 32.7mg | +8.9% | 98.72% | Lab F |
| 23 May 2026 | Cartalax | 6.7 | 20mg | 20.7mg | +3.6% | 96.13% | Lab C |
| 23 May 2026 | Cartalax | 7.2 | 15mg | 17.4mg | +16.2% | 95.17% | Lab C |
| 23 May 2026 | Superdrol Oil | 5.9 | 300mg/ml | 301.3mg/ml | +0.4% | 96.77% | Lab A |
| 21 May 2026 | Boldenone Cypionate | 5.4 | 100mg/ml | 113.8mg/ml | +13.8% | 96.99% | Lab G |
| 21 May 2026 | Lipo-C FAT BLASTER | 5.5 | 100mg/ml | 105.1mg/ml | +5.1% | 97.32% | Lab G |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 8.0 | 5g | 6.0g | +20.3% | 99.58% | Lab F |
| 21 May 2026 | Estradiol Cypionate | 4.0 | 200mg/ml | 208.0mg/ml | +4.0% | 99.83% | Lab D |
| 21 May 2026 | Estradiol Cypionate | 4.4 | 200mg/ml | 240.7mg/ml | +20.3% | 98.34% | Lab D |
| 21 May 2026 | Semax | 4.8 | 2mg | 2.3mg | +16.0% | 98.13% | Lab D |
| 20 May 2026 | Adipotide | 8.2 | 5mg | 4.5mg | -9.5% | 96.87% | Lab G |
| 20 May 2026 | Methylene Blue | 5.9 | 20mg | 22.0mg | +10.2% | 95.06% | Lab A |
| 20 May 2026 | NAD+ Injectable | 4.0 | 300mg/ml | 331.1mg/ml | +10.4% | 98.06% | Lab B |
| 19 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.0 | 30mg | 31.5mg | +5.0% | 99.81% | Lab B |
| 19 May 2026 | Winstrol (Stanozolol) | 9.7 | 20mg | 18.2mg | -8.8% | 97.07% | Lab A |
| 17 May 2026 | AA Water | 4.8 | 30mg | 37.4mg | +24.5% | 95.43% | Lab C |
| 17 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 | 15mg | 16.1mg | +7.1% | 99.68% | Lab B |
| 17 May 2026 | Letrozole | 6.7 | 20mg | 18.9mg | -5.7% | 95.43% | Lab A |
| 17 May 2026 | MT-1 | 6.3 | 20mg | 22.8mg | +14.0% | 95.95% | Lab A |
| 29 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.2 | 30mg | 26.4mg | -11.9% | 97.66% | Lab A |
| 29 Jan 2026 | Lipo-C FAT BLASTER | 5.7 | 300mg/ml | 283.1mg/ml | -5.6% | 97.15% | Lab A |
| 29 Jan 2026 | MOTS-C | 5.9 | 2mg | 1.8mg | -7.7% | 95.40% | Lab C |
| 29 Jan 2026 | Nandrolone Decanoate (Deca) Raw | 4.8 | 500g | 526.6g | +5.3% | 97.83% | Lab F |
| 29 Jan 2026 | Pancragen | 4.0 | 20mg | 22.3mg | +11.4% | 97.00% | Lab C |
| 29 Jan 2026 | Test Base (No Ester) | 4.6 | 100mg/ml | 102.0mg/ml | +2.0% | 99.44% | Lab F |
| 26 Jan 2026 | Methylene Blue | 5.0 | 100mg | 107.3mg | +7.3% | 99.22% | Lab E |
| 26 Jan 2026 | Superdrol Oil | 6.7 | 200mg/ml | 232.6mg/ml | +16.3% | 98.74% | Lab F |
| 26 Jan 2026 | Sustanon 400 | 6.5 | 200mg/ml | 173.2mg/ml | -13.4% | 99.03% | Lab B |
| 19 Jan 2026 | Cerebrolysin | 6.2 | 5mg | 5.8mg | +15.2% | 98.34% | Lab G |
| 19 Jan 2026 | Letrozole | 6.2 | 10mg | 8.9mg | -11.2% | 95.65% | Lab A |
| 19 Jan 2026 | Selank | 7.8 | 15mg | 18.3mg | +21.7% | 97.66% | Lab F |
| 19 Jan 2026 | Turinabol | 4.6 | 50mg | 56.4mg | +12.9% | 95.69% | Lab D |
| 9 Jan 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 6.6 | 10mg | 9.5mg | -5.1% | 99.59% | Lab A |
| 9 Jan 2026 | Turinabol | 6.8 | 10mg | 12.5mg | +24.7% | 96.42% | Lab C |
| 9 Jan 2026 | Turinabol | 7.5 | 25mg | 28.5mg | +14.2% | 97.74% | Lab D |
| 7 Jan 2026 | AA Water | 7.7 | 2mg | 2.4mg | +20.3% | 96.79% | Lab F |
| 7 Jan 2026 | AA Water | 7.4 | 2mg | 1.8mg | -11.8% | 99.78% | Lab G |
| 7 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.2 | 10mg | 10.5mg | +5.3% | 97.63% | Lab D |
| 7 Jan 2026 | Superdrol Oil | 5.7 | 100mg/ml | 110.7mg/ml | +10.7% | 95.02% | Lab F |
| 7 Jan 2026 | Test Base (No Ester) | 4.0 | 250mg/ml | 292.6mg/ml | +17.0% | 96.62% | Lab F |
| 7 Jan 2026 | Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | 7.7 | 100mg/ml | 125.0mg/ml | +25.0% | 99.62% | Lab G |
| 6 Jan 2026 | BPC-157 Arg Oral | 8.4 | 50mg | 54.0mg | +7.9% | 99.67% | Lab D |
| 6 Jan 2026 | EPO | 5.5 | 30mg | 30.2mg | +0.7% | 96.17% | Lab F |
| 6 Jan 2026 | Estradiol Cypionate | 4.0 | 250mg/ml | 306.4mg/ml | +22.6% | 97.18% | Lab E |
| 6 Jan 2026 | MOTS-C | 7.4 | 2mg | 2.1mg | +3.0% | 95.96% | Lab F |
| 6 Jan 2026 | Nandrolone Decanoate (Deca) Raw | 7.7 | 1g | 1.1g | +10.7% | 99.70% | Lab E |
| 29 Dec 2025 | AICAR | 5.4 | 30mg | 31.4mg | +4.8% | 98.92% | Lab F |
| 29 Dec 2025 | EPO | 4.0 | 20mg | 21.4mg | +7.0% | 97.18% | Lab F |
| 29 Dec 2025 | MOTS-C | 7.4 | 5mg | 4.8mg | -4.7% | 99.13% | Lab G |
| 29 Dec 2025 | Nandrolone Decanoate (Deca) Raw | 7.6 | 5g | 5.1g | +1.1% | 99.24% | Lab C |
| 29 Dec 2025 | Semax | 5.1 | 10mg | 11.6mg | +16.3% | 99.62% | Lab C |
| 29 Dec 2025 | Turinabol | 7.2 | 25mg | 22.8mg | -8.8% | 96.10% | Lab F |
| 12 Dec 2025 | AICAR | 6.9 | 10mg | 9.5mg | -5.4% | 97.43% | Lab D |
| 12 Dec 2025 | Boldenone Cypionate | 4.0 | 250mg/ml | 290.3mg/ml | +16.1% | 98.00% | Lab E |
| 12 Dec 2025 | Lipo-C FAT BLASTER | 4.2 | 250mg/ml | 309.4mg/ml | +23.8% | 96.28% | Lab B |
| 12 Dec 2025 | Methylene Blue | 4.2 | 25mg | 22.2mg | -11.4% | 99.04% | Lab G |
| 12 Dec 2025 | MK-677 (Ibutamoren) | 9.8 | 25mg | 27.3mg | +9.3% | 96.48% | Lab G |
| 12 Dec 2025 | MOTS-C | 6.3 | 2mg | 1.8mg | -10.4% | 96.02% | Lab D |
| 11 Dec 2025 | Retatrutide | 7.3 | 10mg | 10.4mg | +4.0% | 99.62% | Lab E |
| 5 Dec 2025 | Tirzepatide | 6.7 | 10mg | 9.4mg | -6.0% | 99.50% | Lab G |
| 5 Dec 2025 | AA Water | 4.2 | 10mg | 10.8mg | +8.1% | 99.69% | Lab B |
| 5 Dec 2025 | Estradiol Cypionate | 4.1 | 200mg/ml | 233.3mg/ml | +16.6% | 98.20% | Lab F |
| 5 Dec 2025 | MT-1 | 7.8 | 20mg | 20.5mg | +2.3% | 96.61% | Lab A |
| 5 Dec 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 5.1 | 100mg | 85.3mg | -14.7% | 97.91% | Lab C |
| 2 Dec 2025 | Retatrutide | 5.8 | 10mg | 9.2mg | -8.0% | 99.40% | Lab G |
| 25 Nov 2025 | Retatrutide | 10.0 | 10mg | 9.95mg | -0.5% | 99.95% | Lab E |
| 23 Nov 2025 | MK-677 (Ibutamoren) | 7.6 | 50mg | 47.4mg | -5.2% | 99.04% | Lab C |
| 23 Nov 2025 | NAD+ Injectable | 4.2 | 200mg/ml | 196.3mg/ml | -1.8% | 96.47% | Lab D |
| 23 Nov 2025 | Selank | 6.8 | 2mg | 2.3mg | +16.0% | 97.00% | Lab E |
| 23 Nov 2025 | Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | 6.6 | 100mg/ml | 97.7mg/ml | -2.3% | 95.37% | Lab A |
| 23 Nov 2025 | Vilon | 8.3 | 30mg | 34.0mg | +13.4% | 96.26% | Lab E |
| 17 Nov 2025 | Boldenone Cypionate | 4.0 | 250mg/ml | 227.6mg/ml | -9.0% | 95.74% | Lab C |
| 17 Nov 2025 | Dapoxetine | 7.8 | 10mg | 9.9mg | -1.1% | 95.77% | Lab F |
| 17 Nov 2025 | DHB (1-Test Cyp) | 4.0 | 100mg/ml | 120.8mg/ml | +20.8% | 96.43% | Lab B |
| 17 Nov 2025 | Nandrolone Decanoate (Deca) Raw | 8.4 | 1g | 1.1g | +12.9% | 96.50% | Lab B |
| 17 Nov 2025 | Vilon | 6.9 | 2mg | 2.0mg | -1.4% | 97.61% | Lab C |
| 14 Nov 2025 | Turinabol | 4.8 | 50mg | 46.5mg | -7.1% | 98.02% | Lab C |
| 5 Nov 2025 | AICAR | 6.9 | 15mg | 17.0mg | +13.2% | 97.85% | Lab G |
| 5 Nov 2025 | Estradiol Cypionate | 4.4 | 200mg/ml | 232.6mg/ml | +16.3% | 95.00% | Lab D |
| 5 Nov 2025 | NAD+ Injectable | 5.9 | 100mg/ml | 120.2mg/ml | +20.2% | 97.16% | Lab C |
| 5 Nov 2025 | Pancragen | 4.9 | 30mg | 32.9mg | +9.6% | 97.83% | Lab B |
| 4 Nov 2025 | Adipotide | 9.9 | 50mg | 59.8mg | +19.5% | 97.60% | Lab C |
| 4 Nov 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.4 | 2mg | 2.5mg | +24.2% | 98.44% | Lab F |
| 4 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 | 5mg | 4.5mg | -9.1% | 96.04% | Lab D |
| 4 Nov 2025 | SS-31 (Elamipretide) Raw | 6.7 | 100g | 123.4g | +23.4% | 99.06% | Lab D |
| 17 Oct 2025 | Retatrutide | 8.0 | 40mg | 40.6mg | +1.5% | 99.95% | Lab E |
| 17 Oct 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 5.1 | 1g | 1.0g | +1.8% | 99.14% | Lab D |
| 17 Oct 2025 | Vilon | 5.6 | 50mg | 57.2mg | +14.3% | 95.88% | Lab F |
| 17 Oct 2025 | Winstrol (Stanozolol) | 7.5 | 20mg | 22.3mg | +11.7% | 99.37% | Lab C |
| 9 Oct 2025 | AICAR | 6.3 | 20mg | 20.7mg | +3.4% | 98.42% | Lab G |
| 9 Oct 2025 | Liraglutide | 8.7 | 30mg | 31.6mg | +5.2% | 95.30% | Lab A |
| 9 Oct 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.3 | 50mg | 54.7mg | +9.4% | 98.81% | Lab F |
| 9 Oct 2025 | SS-31 (Elamipretide) Raw | 6.2 | 1g | 1.0g | +2.5% | 97.30% | Lab C |
| 9 Oct 2025 | SS-31 (Elamipretide) Raw | 6.4 | 10g | 8.8g | -12.0% | 96.73% | Lab C |
| 3 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.8 | 30mg | 28.4mg | -5.2% | 97.70% | Lab G |
| 3 Oct 2025 | Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | 6.2 | 100mg/ml | 112.6mg/ml | +12.6% | 97.49% | Lab B |
| 20 Sep 2025 | GHK-Cu | 4.9 | 50mg | 34.6mg | -30.8% | 100.00% | Lab G |
| 20 Sep 2025 | GHK-Cu | 4.8 | 50mg | 31.2mg | -37.6% | 100.00% | Lab G |